-transparent.png){kind=logo}
New serotonine 2 (5-HT2) antagonists with a monocyclic or bicyclic 2,4(1H,3H)-pyrimidinedione have been prepared and their activities evaluated. In a series of monocyclic compounds, 1-substituted 5-phenyl-2,4(1H,3H)-pyrimidinedione 14 showed potent in vitro activity, and the corresponding 3-substituted 5-phenyl and 6-phenyl derivatives 3, 8 and 20a also showed moderate activity. In the bicyclic compounds, 3-substituted 5,6,7,8-tetrahydro-2,4(1H,3H)-quinazolinedione 33 exhibited the most potent activity among the compounds prepared in this paper. The in vivo antagonist activity of 33 was comparable to that of ketanserin, a typical peripheral 5-HT2 antagonist.
Related Publications
Y Watanabe, and
H Usui, and
T Shibano, and
T Tanaka, and
M Kanao
October 1976,
Biochimica et biophysica acta,
Y Watanabe, and
H Usui, and
T Shibano, and
T Tanaka, and
M Kanao
October 1978,
International journal of peptide and protein research,
Y Watanabe, and
H Usui, and
T Shibano, and
T Tanaka, and
M Kanao
September 1992,
Journal of medicinal chemistry,
Y Watanabe, and
H Usui, and
T Shibano, and
T Tanaka, and
M Kanao
July 1989,
Journal of medicinal chemistry,
Y Watanabe, and
H Usui, and
T Shibano, and
T Tanaka, and
M Kanao
January 1988,
Annales pharmaceutiques francaises,
Y Watanabe, and
H Usui, and
T Shibano, and
T Tanaka, and
M Kanao
August 2008,
Acta crystallographica. Section E, Structure reports online,
Y Watanabe, and
H Usui, and
T Shibano, and
T Tanaka, and
M Kanao
March 2003,
Inorganic chemistry,
Y Watanabe, and
H Usui, and
T Shibano, and
T Tanaka, and
M Kanao
January 2001,
Bollettino chimico farmaceutico,
Y Watanabe, and
H Usui, and
T Shibano, and
T Tanaka, and
M Kanao
April 1965,
Acta pharmaceutica Suecica,
Y Watanabe, and
H Usui, and
T Shibano, and
T Tanaka, and
M Kanao
November 1988,
Journal of medicinal chemistry,
